Related references
Note: Only part of the references are listed.Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors
Ana Castro et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE
D Alonso et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors:: New disease-modifying agents for Alzheimer's disease
P Muñoz-Ruiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetyl-cholinesterase inhibitors
I Dorronsoro et al.
ARCHIV DER PHARMAZIE (2005)
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
O Almkvist et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months
T Darreh-Shori et al.
NEUROLOGY (2002)
Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimer's Disease
Ana Castro et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2001)
Share Paper
